NCT06296147Completed
Virtual Reality Headset and/or Aromatherapy for Patients Undergoing a Transperineal Prostate Biopsy
A Randomized, Controlled Trial: Impact on Patient Experience in Patients Assigned to Virtual Reality Headset; Aromatherapy Patch; Virtual Reality + Aromatherapy; or Standard of Care for Transperineal Prostate Biopsy
Source: ClinicalTrials.gov · Last updated 25 Aug 2026
Brief summary (registry, in English)
The purpose of this study is to evaluate if a VR headset and/or aromatherapy can be used to reduce patient pain, anxiety, and embarrassment during a transperineal biopsy (TPBx) compared to standard of care (SOC). The primary objective is to evaluate differences in self-reported pain, fear, or embarrassment during and after the procedure between the VR Group, Aromatherapy Group, VR+Aromatherapy Group, and the Control group.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 208 (actual)
- First submitted
- 7 Feb 2024
- Start date
- 20 May 2024
- Primary completion date
- 1 Mar 2026
- Lead sponsor
- University of Pittsburgh
- Diseases
- Prostate cancer
- NCT number
- NCT06296147
What you commit to
- Study type: Interventional
- Participants enrolled: 208
- From 20 May 2024 to the primary completion date, 1 Mar 2026
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patient has a known psychiatric or mental illness that would impede use of the VR device or aromatherapy patch
- Patient has a history of seizures or epilepsy or is on a medication that would lower the threshold for a seizure
- Patient has a history of reactions to noxious odors
Other
- Patient has severe hearing or vision problems that would impair use of the VR headset (under the physician's discretion)
Who the study is looking for
- Patient is 18 years or older
- Patient is male
- Patient is due for a transperineal prostate biopsy
- Patient signed and dated informed consent form on Redcap agreeing to participate in the study
Age in the registry: 18 years to - · Sex: Male · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| University of Pittsburgh Medical Center - Shadyside Hospital Coordinator of this site? Confirm its status | Pittsburgh | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.